Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amgen (NQ: AMGN )

255.26 +2.21 (+0.87%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 27, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,678,950
Open 253.50
Bid (Size) 254.65 (19)
Ask (Size) 256.40 (1)
Prev. Close 253.05
Today's Range 250.92 - 256.23
52wk Range 198.64 - 258.45
Shares Outstanding N/A
Dividend Yield 2.76%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
$100 Invested In Amgen 15 Years Ago Would Be Worth This Much
Amgen (NASDAQ:AMGN) has outperformed the market over the past 15 years by 3.74% on an annualized basis producing an average annual return of 10.5%. Currently, Amgen has a market capitalization of... 
Via Benzinga
Mirati Therapeutics Plunges As Its Hopes To Take On Amgen In Lung Cancer Crash
Mirati is unlikely to carve out share with a drug that didn't differentiate, analysts say. 
Via Investor's Business Daily

Performance

YTD
+12.60%
+12.60%
1 Month
+7.19%
+7.19%
3 Month
+12.71%
+12.71%
6 Month
+25.30%
+25.30%
1 Year
+7.28%
+7.28%

More News

Read More
Quant Ratings Updated on 75 Stocks
Via InvestorPlace
7 Retirement Stocks to Buy to Turbocharge Your Savings
Via InvestorPlace
Analyst Ratings for Amgen
Via Benzinga
7 Cheap Biotech Stocks to Buy Now
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2022
Via Benzinga
How Heart Drugs Could Pump $10 Billion Into Merck's Coffers
Via Investor's Business Daily
7 Dividend Stocks to Boost Your Retirement Savings
Via InvestorPlace
Peering Into Amgen's Recent Short Interest
Via Benzinga
5 Beaten-Down Blue-Chip Stocks to Buy Now
Via InvestorPlace
NASDAQ: AMGN Investor Notice: Investigation over Possible Securities Laws Violations by Amgen Inc.
Via SBWire
Executives Sell More Than $220M Of 3 Stocks
Via Benzinga
10 Biggest Price Target Changes For Tuesday
Via Benzinga
Markets Sell Off Following Last Week's Federal Reserve Decision
Via Benzinga
This Is What Whales Are Betting On Amgen
Via Benzinga
Week In Review: OrbiMed Plans To Raise $1.1 Billion For Fifth Asia Fund
Via Talk Markets
Markets Close Turbulent Week On A Down Note
Via Benzinga
9 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
7 Defensive Dividend Healthcare Stocks to Buy Now
Via InvestorPlace
Ongoing Investigation Reminder: The Schall Law Firm Encourages Investors in Amgen Inc. with Losses of $100,000 to Contact the Firm
Via NewMediaWire
Ongoing Investigation Reminder: The Schall Law Firm Encourages Investors in Amgen Inc. with Losses of $100,000 to Contact the Firm
Via NewMediaWire
Ongoing Investigation Alert: The Schall Law Firm Encourages Investors in Amgen Inc. with Losses of $100,000 to Contact the Firm
Via NewMediaWire
INVESTIGATION NOTICE: The Schall Law Firm Encourages Investors in Amgen Inc. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
Analyzing Amgen's Short Interest
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.